4154
M. M. Ahmed, G. A. O’Doherty / Tetrahedron Letters 46 (2005) 4151–4155
Nollstadt, K.; Schmatz, D.; Schwartz, R.; Hammond,
BnO
HO OBn
M.; Balkovec, J.; Van Middlesworth, F. L. Antimicrob.
Agent Chemother. 1992, 36, 1648–1657.
O
OBn
Py•TsOH
HO
+
1d 12
HO
H
4. (a) Baguley, B. C.; Rommele, G.; Gruner, J.; Wehrli, W.
Eur. J. Biochem. 1979, 97, 345–351; (b) Perez, P.; Varona,
R.; Garcia-Acha, I.; Duran, A. FEBS Lett. 1981, 129,
249–252; (c) Varona, R.; Perez, P.; Duran, A. FEMS
Microbiol. Lett. 1983, 20, 243–247; (d) Rommele, G.;
Traxler, P.; Wehrli, W. J. Antibiot. 1983, 36, 1539–
1542.
5. (a) Kaneto, R.; Chiba, H.; Agematu, H.; Shibamoto, N.;
Yoshioka, T.; Nishida, H.; Okamoto, R. J. Antibiot. 1993,
46, 247–250; (b) Chiba, H.; Kaneto, R.; Agematu, H.;
Shibamoto, N.; Yoshioka, T.; Nishida, H.; Okamoto, R.
J. Antibiot. 1993, 46, 356–358; (c) Aoki, M.; Andoh, T.;
Ueki, T.; Masuyoshi, S.; Sugawara, K.; Oki, T. J. Antibiot.
1993, 46, 952–960; (d) Okada, H.; Nagashima, M.; Suzuki,
H.; Nakajima, S.; Kojiri, K.; Suda, H. J. Antibiot. 1996,
49, 103–106; (e) Traxler, P.; Fritz, H.; Fuhrer, H.; Richter,
W. J. J. Antibiot. 1980, 33, 967–978.
MeOH
95%
O
1d
2:1
BnO
HO
Py•TsOH
O
OBn
+
1d 12
BnO
HO
MeOH
95%
2:1
OH
O
12
H
Scheme 7. Spiroketal equilibration.
analysis indicated that both solutions had equilibrated
to the original 2:1 ratio. It is important to note that
these equilibrated mixtures of isomers were re-isolated
in excellent yields (95% yield, Scheme 7); therefore, indi-
cated that neither isomer was being selectively destroyed
under the reaction conditions.
6. For other approaches to the papulacandin ring system see:
(a) Danishefsky, S.; Philips, G.; Ciufolini, M. Carbohydr.
Res. 1987, 171, 317–327; (b) Parker, K. A.; Georges, A. T.
Org. Lett. 2000, 2, 497–499; (c) Friesen, R. W.; Sturino, C.
F. J. Org. Chem. 1990, 55, 5808–5810; (d) Friesen, R. W.;
Loo, R. W.; Sturino, C. F. Can. J. Chem. 1994, 72, 1262–
1272; (e) Friesen, R. W.; Daljeet, A. K. Tetrahedron Lett.
1990, 31, 6133–6136; (f) Dubois, E.; Beau, J.-M. Tetrahe-
dron Lett. 1990, 31, 5165–5168; (g) Dubois, E.; Beau,
J.-M. Carbohydr. Res. 1992, 223, 157–167; (h) Rosenblum,
S.; Bihovsky, M. J. Am. Chem. Soc. 1990, 112, 2746–2748;
(i) Czernecki, S.; Perlat, M. C. J. Org. Chem. 1991, 56,
6289–6292; (j) McDonald, F. E.; Zhu, H. Y. H.; Holm-
quist, C. R. J. Am. Chem. Soc. 1995, 117, 6605–6606; (k)
Schmidt, R. R.; Frick, W. Tetrahedron 1988, 44, 7163–
7169; (l) Carretero, J. C.; Eugenio de Diego, J.; Hamdou-
chi, C. Tetrahedron 1999, 55, 15159–15166.
In summary, we have developed a concise de novo
approach to both the pyranose and furanose forms of a
galacto-papulacandin (1d and 12) from 2,4-dienone 3 in
four steps and 33% overall yield. The complete synthesis
requires only nine total steps from commercially avail-
able 3,5-dibenzyloxybenzyl alcohol 8, which has pro-
vided significant quantities (ꢀ500 mg in three batch) of
material for both biological study and further synthetic
efforts toward papulacandin C.
Acknowledgements
7. Barrett, A. G. M.; Pena, M.; Willardsen, J. A. J. Org.
Chem. 1996, 61, 1082–1100.
We are grateful to NIH (GM63150) and NSF (CHE-
0415469) for the support of our research program and
NSF-EPSCoR (0314742) for a 600 MHz NMR at
WVU.
8. (a) Hitchcock, S. A.; Gregory, G. S.; Kraynack, E. A.;
Mayhugh, D. R. 218th ACS National Meeting, New
Orleans, August 22–26, 1999; (b) Hitchcock, S. A. In
Frontiers of Biotechnology & Pharmaceuticals; Science:
New York, 2002; Vol. 3, pp 229–242.
9. (a) Balachari, D.; OꢀDoherty, G. A. Org. Lett. 2000, 2,
863–866; (b) Balachari, D.; OꢀDoherty, G. A. Org. Lett.
2000, 2, 4033–4036.
Supplementary data
10. An Achmatowicz reaction is the oxidative rearrangement
of furfuryl alcohols to 2-substituted 6-hydroxy-2H-pyran-
3(6H)-ones. For examples see: (a) Achmatowicz, O.;
Bielski, R. Carbohydr. Res. 1977, 55, 165–176; (b) Grap-
sas, I. K.; Couladouros, E. A.; Georgiadis, M. P. Pol. J.
Chem. 1990, 64, 823–826; For its use in de novo
carbohydrate synthesis see: Ref. 9, and (c) Harris, J. M.;
Keranen, M. D.; OꢀDoherty, G. A. J. Org. Chem. 1999, 64,
2982–2983; (d) Harris, J. M.; Keranen, M. D.; Nguyen,
H.; Young, V. G.; OꢀDoherty, G. A. Carbohydr. Res. 2000,
328, 17–36.
Supplementary data associated with this article can be
References and notes
1. (a) Schmatz, D. M.; Romancheck, M. A.; Pittarelli, L. A.;
Schwartz, R. E.; Fromtling, R. A.; Nollstadt, K. H.; Van
Middlesworth, F. L.; Wilson, K. E.; Turner, M. J. Proc.
Natl. Acad. Sci. U.S.A. 1990, 87, 5950–5954; (b) Kovacs,
J.; Masur, H. J. Infect. Dis. 1988, 158, 254–259.
11. (a) Hunter, T. J.; OꢀDoherty, G. A. Org. Lett. 2001, 3,
1049–1052; (b) Hunter, T. J.; OꢀDoherty, G. A. Org. Lett.
2002, 4, 4447–4450; (c) Smith, C. M.; OꢀDoherty, G. A.
Org. Lett. 2003, 5, 1959–1962.
2. Traxler, P.; Gruner, J.; Auden, J. A. L. J. Antibiot. 1977,
30, 289–296.
3. (a) Van Middlesworth, F.; Omstead, M. N.; Schmatz, D.;
Bartizal, K.; Fromtling, R.; Bills, G.; Nollstadt, K.;
Honeycutt, S.; Zweerink, M.; Garrity, G.; Wilson, K. J.
Antibiot. 1991, 44, 45–51; (b) Jabri, E. D. R.; Quigley, M.;
Alders, M.; Hrmova, M.; Taft, C. S.; Phelps, P.; Selitren-
nikoff, C. P. Curr. Microbiol. 1989, 19, 153–161; (c)
Bartizal, K.; Abruzzo, G.; Trainor, C.; Krupa, D.;
12. Ahmed, Md. M.; Berry, B. P.; Hunter, T. J.; Tomcik, D.
J.; OꢀDoherty, G. A. Org. Lett. 2005, 7, 745–
748.
13. It is worth noting that the use of i-propanol was critical to
prevent polymerization of enal 7, see: Ref. 14.
14. Narkunan, K.; Nagarajan, M. J. Org. Chem. 1994, 59,
6386–6390.